The recommended essential panels for DLBCL include CD3, CD20, Ki-67, CD10, BCL-6, MUM1, BCL-2, C-MYC, and EBV in situ hybridization (ISH) [36]. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.